Table 5.
Early and long-term functional outcomes according to PASO criteria.
| Variable | Overall Cohort |
Total Adrenalectomy |
Partial Adrenalectomy |
p |
|---|---|---|---|---|
| Complete clinical success | ||||
| - No medication/Controlled BP | 54 (60%) | 33 (54%) | 21 (72.4%) | 0.097 |
| Partial clinical success | 16 (17.7%) | 14 (23%) | 2 (6.8%) | |
| - Drug escalation (Controlled BP) | 8 (8.9%) | 7 (11.5%) | 1 (3.4%) | |
| - Switch to a lower class of medication (Controlled BP) | 2 (2.2%) | 2 (3.3%) | - | |
| - No drugs (Moderate BP reduction) | 4 (4.4%) | 4 (6.6%) | - | 0.136 |
| - Switch to comparable medication (Moderate BP reduction) | 2 (2.2%) | 1 (1.6%) | 1 (3.4%) | |
| Absent clinical success | 20 (22.3%) | 14 (23%) | 6 (20.7%) | |
| - Unchanged dosage medication | 14 (15.6%) | 9 (14.8%) | 5 (17.2%) | |
| - Increased dosage | 3 (3.3%) | 3 (4.9%) | - | 0.136 |
| - Switch to a stronger class of medication | 3 (3.3%) | 2 (3.3%) | 1 (3.4%) |